Skip to main content
Premium Trial:

Request an Annual Quote

Euroimmun to Distribute GenScript Serology COVID-19 Test in US, Canada

NEW YORK – GenScript USA announced on Thursday a deal with PerkinElmer company Euroimmun to distribute the GenScript cPass SARS-CoV-2 Neutralization Antibody Detection Kit in the US and Canada.

The kit measures a relative concentration of neutralizing antibodies against SARS-CoV-2 in patients and received Emergency Use Authorization from the US Food and Drug Administration in November 2020. It is also CE marked and has received regulatory approval in Brazil and Argentina and provisional approval in Singapore, the Piscataway, New Jersey-based subsidiary of GenScript Biotech said in a statement.

"We believe this collaboration can further enhance the significant contribution cPass has provided to the fight against COVID-19 and will continue to play an important role as we move towards normalcy," GenScript USA Senior Director of Corporate Development Michael Lau said in a statement.